In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide

Oligonucleotides provide novel reagents for Inhibition of gene expression because of their high affinity binding to specific nucleotide sequences. We describe a 38 base, single-stranded DNA that forms a triple helix or ‘triplex’ on progesterone response elements of a target gene. This triplex-formin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nucleic acids research 1993-06, Vol.21 (12), p.2789-2796
Hauptverfasser: Ing, Nancy H., Beekman, Johanna M., Kessler, Donald J., Murphy, Mark, Jayaraman, Krishna, Zendegui, Joseph G., Hogan, Michael E., O'Malley, Bert W., Tsai, Ming-Jer
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Oligonucleotides provide novel reagents for Inhibition of gene expression because of their high affinity binding to specific nucleotide sequences. We describe a 38 base, single-stranded DNA that forms a triple helix or ‘triplex’ on progesterone response elements of a target gene. This triplex-forming oligonucleotide binds with a Kd= 100 nM at 37°C and physiological pH, and blocks binding of progesterone receptors to the target. Furthermore, It completely inhibited progesterone receptor-dependent transcription In vitro. To approach In vivo conditions, triplex-forming ollgonucleotides were tested In cell transfection studies. The derivation of the oligonucleotides with cholesterol enhanced their cellular uptake and nuclear concentration by at least four-fold. The cholesterol-derivatized triplex-forming oligonucleotide specifically inhibited transcription of the PRE-containing reporter gene in cells when applied to the medium at micromolar concentrations. This Is the first demonstration of steroid-responsive gene inhibition by triplex formation and joins the growing body of evidence Indicating that oligonucleotides have therapeutic potential.
ISSN:0305-1048
1362-4962
DOI:10.1093/nar/21.12.2789